Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC

NCT06815679 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Failure
Pneumonia

Interventions

DRUG: salbutamol 2.5 mg via vibrating mesh nebulizer (VMN)

Sponsor

Università degli Studi di Ferrara

Collaborators

[object Object]